Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Blueprint Medicines Corp (NASDAQ: BPMC) was $94.81 for the day, up 0.22% from the previous closing price of $94.60. In other words, the price has increased by $0.22 from its previous closing price. On the day, 0.56 million shares were traded. BPMC stock price reached its highest trading level at $95.015 during the session, while it also had its lowest trading level at $92.66.
Ratios:
Our analysis of BPMC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.27 and its Current Ratio is at 3.32. In the meantime, Its Debt-to-Equity ratio is 2.34 whereas as Long-Term Debt/Eq ratio is at 1.96.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, JP Morgan on November 14, 2024, initiated with a Overweight rating and assigned the stock a target price of $126.
On October 24, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $88.
On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $140.Stephens initiated its Overweight rating on May 14, 2024, with a $140 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Nov 20 ’24 when LONNEL COATS bought 10,000 shares for $94.60 per share.
Albers Jeffrey W. sold 5,000 shares of BPMC for $510,000 on Nov 07 ’24. The Director now owns 157,557 shares after completing the transaction at $102.00 per share. On Nov 07 ’24, another insider, Albers Jeffrey W., who serves as the Director of the company, bought 5,000 shares for $102.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BPMC now has a Market Capitalization of 6022880768 and an Enterprise Value of 6021414912. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.86 while its Price-to-Book (P/B) ratio in mrq is 19.21. Its current Enterprise Value per Revenue stands at 13.861 whereas that against EBITDA is -22.971.
Stock Price History:
Over the past 52 weeks, BPMC has reached a high of $121.90, while it has fallen to a 52-week low of $63.50. The 50-Day Moving Average of the stock is 5.34%, while the 200-Day Moving Average is calculated to be -1.13%.
Shares Statistics:
BPMC traded an average of 614.18K shares per day over the past three months and 644300 shares per day over the past ten days. A total of 63.53M shares are outstanding, with a floating share count of 62.34M. Insiders hold about 1.86% of the company’s shares, while institutions hold 103.58% stake in the company. Shares short for BPMC as of 1730332800 were 4133244 with a Short Ratio of 6.73, compared to 1727654400 on 3529107. Therefore, it implies a Short% of Shares Outstanding of 4133244 and a Short% of Float of 7.33.
